Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Jul 2;309(6946):2–3. doi: 10.1136/bmj.309.6946.2

Triglyceride concentration and coronary heart disease.

A M Garber, A L Avins
PMCID: PMC2542639  PMID: 8044062

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assmann G., Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. Am J Cardiol. 1992 Sep 15;70(7):733–737. doi: 10.1016/0002-9149(92)90550-i. [DOI] [PubMed] [Google Scholar]
  2. Avins A. L., Haber R. J., Hulley S. B. The status of hypertriglyceridemia as a risk factor for coronary heart disease. Clin Lab Med. 1989 Mar;9(1):153–168. [PubMed] [Google Scholar]
  3. Avins A. L., Hulley S. B. Joint effects of serum triglycerides and LDL and HDL cholesterol. Circulation. 1993 Jan;87(1):300–301. [PubMed] [Google Scholar]
  4. Bengtsson C., Björkelund C., Lapidus L., Lissner L. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. BMJ. 1993 Nov 27;307(6916):1385–1388. doi: 10.1136/bmj.307.6916.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Criqui M. H., Heiss G., Cohn R., Cowan L. D., Suchindran C. M., Bangdiwala S., Kritchevsky S., Jacobs D. R., Jr, O'Grady H. K., Davis C. E. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993 Apr 29;328(17):1220–1225. doi: 10.1056/NEJM199304293281702. [DOI] [PubMed] [Google Scholar]
  6. Hulley S. B., Newman T. B., Grady D., Garber A. M., Baron R. B., Browner W. S. Should we be measuring blood cholesterol levels in young adults? JAMA. 1993 Mar 17;269(11):1416–1419. [PubMed] [Google Scholar]
  7. Lindenstrøm E., Boysen G., Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ. 1994 Jul 2;309(6946):11–15. doi: 10.1136/bmj.309.6946.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Manninen V., Tenkanen L., Koskinen P., Huttunen J. K., Mänttäri M., Heinonen O. P., Frick M. H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992 Jan;85(1):37–45. doi: 10.1161/01.cir.85.1.37. [DOI] [PubMed] [Google Scholar]
  9. Phillips A. N., Smith G. D. How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991;44(11):1223–1231. doi: 10.1016/0895-4356(91)90155-3. [DOI] [PubMed] [Google Scholar]
  10. Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stensvold I., Tverdal A., Urdal P., Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ. 1993 Nov 20;307(6915):1318–1322. doi: 10.1136/bmj.307.6915.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES